Venous thromboembolism (VTE) is a health concern with serious morbidity and
mortality. While athletes are perceived as healthy with a lower VTE incidence than
general population, they are exposed to many unique risk factors. VTE in athletes
presents unique diagnostic and therapeutic challenges, what impacts their ability to
compete. This review brings together information to explore the understanding of
VTE in athletes, focusing on its pathophysiology, diagnosis, management and
screening. Sportsmen are exposed to sport-acquired risk factors and may have
underlying genetic tendencies disrupting the hemostasis. Diagnosis can be difficult
as symptoms mimic common sports injuries. Standard therapy prohibited playing
contact sports while on anticoagulation. Invention of direct oral anticoagulants led
to individualized, intermittent dosing strategies, which allows competing again
while lowering bleeding risk. Patients with personal or family history should be
considered for screening. Further research is necessary for treatment optimization
strategies and better long-term outcomes. For this paper we performed a thorough
search of literature by using databases: PubMed, Medline, and Google Scholar,
where "Venous thrombosis in athletes" or "Hypercoagulability in athletes" appeared
in the title, abstract, or keywords. Athletes, despite their professional physical shape
and their overall good health, face specific risks of VTE, often connected to sports
discipline. Keeping these factors in mind, being aware of potential misdiagnosis
and its consequences, and the approach heavily relying on individualized treatment
are crucial for managing VTE in this population and making a return to play
possible, while minimizing risks.
Keywords: athletes, venous thromboembolism, deep vein thrombosis, pulmonary
embolism, anticoagulation